Jundu Investment

Jundu Investment is a China-based private investment firm focused on venture capital and private equity investing rather than operating as a drug-development or healthcare company. Public business-directory and startup-database sources identify it as an active private investor founded in 2015, with legal naming variants tied to Tibet/Xizang and operations associated with Lhasa and Ningbo. The firm appears to participate across multiple sectors, including occasional investments in biotech and healthcare companies, but it is not itself a life sciences developer, manufacturer, CRO, or pharmaceutical company. No evidence was found that Jundu Investment has an internal therapeutic pipeline, proprietary drug platform, or clinical-stage assets. For biotech-analyst purposes, it is best classified as a financial sponsor/investor with some exposure to healthcare deals, not as a healthcare operating company.